| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | Director | Common Shares | 56,499 | $476,287 | $8.43 | 21 Nov 2024 | Direct |
| Aurinia Pharmaceuticals Inc. | Director | Director Stock Option (right to buy) | 18,641 | 21 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 21 Nov 2024 | 2 | $0 | 4 | Director | 25 Nov 2024, 16:28 |
| AUPH | Aurinia Pharmaceuticals Inc. | 21 May 2024 | 1 | -$28,390 | 4 | Director | 22 May 2024, 16:11 |
| AUPH | Aurinia Pharmaceuticals Inc. | 18 May 2023 | 5 | -$98,334 | 4 | Director | 23 May 2023, 17:19 |
| AUPH | Aurinia Pharmaceuticals Inc. | 18 May 2022 | 2 | +$36,200 | 4/A | Director | 11 Jul 2022, 06:16 |
| AUPH | Aurinia Pharmaceuticals Inc. | 14 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 21:19 |